The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.45
Bid: 94.05
Ask: 94.20
Change: 1.10 (1.18%)
Spread: 0.15 (0.159%)
Open: 93.40
High: 95.65
Low: 93.40
Prev. Close: 93.35
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Primary Health Properties

8 Feb 2019 09:41



Form 8.3 - Primary Health Properties

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Investec Wealth & Investment
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Primary Health Properties plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 7th February 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” Yes – Medicx Limited 7th February 2019

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:37,211,9364.79%  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:37,211,9364.79%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
Ordinary Shares Sale 8,000 116.221p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
N/A

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
N/A

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

 8th February 2019
 Phil Beardwell Chartered FCSI
 020 7597 1356

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
22nd Aug 20222:11 pmRNSHolding(s) in Company
15th Aug 20224:14 pmRNSApplication for Listing and Total Voting Rights
5th Aug 20225:00 pmRNSConvertible Bond Adjustment
27th Jul 20227:00 amRNSInterim Results
25th Jul 20227:00 amRNSAcquisition
14th Jul 202210:47 amRNSScrip dividend reference price
11th Jul 20227:00 amRNSInvestor Presentation
7th Jul 20227:00 amRNSDisposal of 13 assets for £27.7 million
30th Jun 20227:00 amRNSNotice of Interim Results
30th Jun 20227:00 amRNSDividend Declaration
28th Jun 20224:57 pmRNSDirector/PDMR Shareholding
28th Jun 20224:53 pmRNSDirector/PDMR Shareholding
24th May 20222:33 pmRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
24th May 20221:25 pmRNSDirector/PDMR Shareholding
16th May 202211:00 amRNSApplication for listing and total voting rights
3rd May 20225:35 pmRNSDirector Declaration
27th Apr 20224:51 pmRNSResult of AGM
27th Apr 20227:00 amRNSQ1 2022 Trading Update
20th Apr 20224:44 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSAcquisition
11th Apr 20227:00 amRNSFirst Net Zero Carbon ("NZC") Direct Development
7th Apr 20225:30 pmRNSDirector/PDMR Shareholding
7th Apr 20225:30 pmRNSDirector/PDMR Shareholding
7th Apr 202211:20 amRNSScrip dividend reference price
7th Apr 202211:20 amRNSNotice of Interim Dividend - Replacement
1st Apr 20227:00 amRNSAcquisition
24th Mar 20227:00 amRNSDividend Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:15 amRNSAnnual Financial Report
7th Mar 20225:30 pmRNSDirector/PDMR Shareholding
7th Mar 20225:30 pmRNSDirector/PDMR Shareholding
4th Mar 20225:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20227:01 amEQSEdison Investment Research Limited: Primary Health Properties (PHP): Continuing strong DPS growth well supported
23rd Feb 20223:46 pmRNSDirector/PDMR Shareholding
22nd Feb 202212:22 pmRNSDirector/PDMR Shareholding
21st Feb 202211:51 amRNSApplication for listing
16th Feb 20227:01 amRNSLaunch of Net Zero Carbon (“NZC”) Framework
16th Feb 20227:00 amRNSPreliminary Results
15th Feb 20224:47 pmRNSHolding(s) in Company
14th Feb 202210:52 amRNSHolding(s) in Company
10th Feb 202211:12 amRNSHolding(s) in Company
9th Feb 20223:10 pmRNSDirector/PDMR Shareholding
9th Feb 20223:10 pmRNSDirector/PDMR Shareholding
20th Jan 202211:41 amRNSScrip dividend reference price
19th Jan 20227:00 amRNSNotice of Preliminary Results
18th Jan 20223:24 pmRNSHolding(s) in Company
13th Jan 20224:58 pmRNSHolding(s) in Company
11th Jan 202211:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.